Fingerprint
Dive into the research topics of 'Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically